GB Sciences Licenses Patent To Develop New Cannabis-Based Therapies For The Treatment Of Heart Disease Pharmaceutical Investing
Dimension Therapeutics Announces FDA Acceptance of Investigational New Drug Application for DTX301 to Treat OTC Deficiency Pharmaceutical Investing
RedHill Biopharma Announces Phase IIa 48-Week Final Results for RHB-104 in Multiple Sclerosis Pharmaceutical Investing
Neuralstem Announces the Closing of $20 Million Strategic Investment from Tianjin Pharmaceutical Group International Holdings Pharmaceutical Investing
Reata Pharmaceuticals Announces Requested Withdrawal of Registration Statement Due to Adverse Market Conditions Pharmaceutical Investing
Cytokinetics Announces New Data Presented at the International Symposium on ALS/MND Pharmaceutical Investing
Novartis LEE011 (ribociclib) Plus Letrozole Analyses Show Superior PFS in First-Line HR+/HER2- Advanced Breast Cancer Life Science Investing
